Table 9.
Probable biological activities of steroids derived from soft coral species estimated by PASS.
| No. | Antitumor and Related Activity, (Pa) * | Lipid Metabolism Regulators, (Pa) * | Additional Biological Activity, (Pa) * |
|---|---|---|---|
| 157 | Antineoplastic (0.749) | Anti-hypercholesterolemic (0.825) | Anti-inflammatory (0.881) |
| 158 | Antineoplastic (0.701) Prostate disorders treatment (0.629) |
Anti-hypercholesterolemic (0.929) Hypolipemic (0.645) |
Anti-seborrheic (0.868) Radioprotector (0.801) |
| 159 | Apoptosis agonist (0.791) Antineoplastic (0.787) |
Hypolipemic (0.680) |
Anti-psoriatic (0.795) Immunosuppressant (0.726) |
| 160 | Antineoplastic (0.913) Apoptosis agonist (0.862) Proliferative diseases treatment (0.687) |
Atherosclerosis treatment (0.628) Anti-hypercholesterolemic (0.587) |
Anti-eczematic (0.844) Anti-psoriatic (0.820) |
| 161 | Antineoplastic (0.860) Apoptosis agonist (0.851) Proliferative diseases treatment (0.700) |
Anti-hypercholesterolemic (0.789) Atherosclerosis treatment (0.724) Cholesterol synthesis inhibitor (0.617) |
Anti-osteoporotic (0.913) Nootropic (0.870) |
| 162 | Antineoplastic (0.872) Apoptosis agonist (0.811) Proliferative diseases treatment (0.786) |
Anti-hypercholesterolemic (0.943) Hypolipemic (0.730) Atherosclerosis treatment (0.648) |
Anesthetic general (0.917) Respiratory analeptic (0.869) Nootropic (0.698) |
| 163 | Antineoplastic (0.937) Apoptosis agonist (0.906) Proliferative diseases treatment (0.886) Antiparkinsonian, rigidity relieving (0.729) Multiple sclerosis treatment (0.565) |
Anti-eczematic (0.973) Anti-psoriatic (0.963) Anti-osteoporotic (0.961) Hyperparathyroidism treatment (0.842) Hypercalcemia treatment (0.509) |
|
| 164 | Antineoplastic (0.706) Proliferative diseases treatment (0.608) |
Anti-hypercholesterolemic (0.882) Atherosclerosis treatment (0.723) Cholesterol synthesis inhibitor (0.632) |
Hepatic disorders treatment (0.824) Anti-osteoporotic (0.665) |
| 165 | Antineoplastic (0.750) |
Anti-hypercholesterolemic (0.791) Atherosclerosis treatment (0.700) Acute neurologic disorders treatment (0.635) |
Hepatic disorders treatment (0.816) Anesthetic general (0.774) Anti-osteoporotic (0.663) |
| 166 | Antineoplastic (0.694) Apoptosis agonist (0.578) Proliferative diseases treatment (0.542) |
Anti-hypercholesterolemic (0.852) Hypolipemic (0.788) Atherosclerosis treatment (0.744) |
Anti-eczematic (0.870) Hepatic disorders treatment (0.817) Anti-osteoporotic (0.678) |
| 167 | Antineoplastic (0.789) Apoptosis agonist (0.726) Proliferative diseases treatment (0.608) |
Anti-hypercholesterolemic (0.891) Atherosclerosis treatment (0.630) Acute neurologic disorders treatment (0.560) |
Anti-eczematic (0.894) Anti-psoriatic (0.777) Anti-osteoporotic (0.736) |
| 168 | Proliferative diseases treatment (0.947) Dementia treatment (0.657) |
Neuroprotector (0.981) Anti-hypercholesterolemic (0.971) Hypolipemic (0.778) |
Respiratory analeptic (0.987) Hepatoprotectant (0.945) Anesthetic general (0.903) |
| 169 | Proliferative diseases treatment (0.920) Antineoplastic (0.841) Dementia treatment (0.661) |
Anti-hypercholesterolemic (0.962) Neuroprotector (0.952) Acute neurologic disorders treatment (0.783) |
Respiratory analeptic (0.991) Anesthetic general (0.922) Spasmolytic (0.719) |
| 170 | Antineoplastic (0.793) Proliferative diseases treatment (0.605) |
Anesthetic general (0.815) Cardiotonic (0.770) |
|
| 171 | Antineoplastic (0.872) Alzheimer’s disease treatment (0.634) Proliferative diseases treatment (0.625) |
Neuroprotector (0.732) Hypolipemic (0.592) Acute neurologic disorders treatment (0.557) |
Anti-inflammatory (0.923) Nootropic (0.672) |
| 172 | Antineoplastic (0.871) Alzheimer’s disease treatment (0.681) Dementia treatment (0.576) |
Neuroprotector (0.762) Anti-hypercholesterolemic (0.633) Neurodegenerative diseases treatment (0.618) |
Respiratory analeptic (0.894) Anesthetic general (0.890) |
| 173 | Proliferative diseases treatment (0.922) Antineoplastic (0.842) |
Anti-hypercholesterolemic (0.859) Neuroprotector (0.706) |
Respiratory analeptic (0.962) Anti-ischemic, cerebral (0.864) |
| 174 | Proliferative diseases treatment (0.935) Antineoplastic (0.837) Dementia treatment (0.616) |
Anti-hypercholesterolemic (0.927) Neuroprotector (0.773) Hypolipemic (0.584) |
Anti-ischemic, cerebral (0.944) Respiratory analeptic (0.940) Antithrombotic (0.720) |
| 175 | Antineoplastic (0.793) |
Anti-hypercholesterolemic (0.954) Neuroprotector (0.754) Hypolipemic (0.704) |
Respiratory analeptic (0.979) Anesthetic general (0.927) Anti-ischemic, cerebral (0.679) |
| 176 | Antineoplastic (0.893) Proliferative diseases treatment (0.768) |
Anti-hypercholesterolemic (0.899) Atherosclerosis treatment (0.754) |
Respiratory analeptic (0.979) Immunomodulator (HIV) (0.912) |
| 177 | Antineoplastic (0.812) Dementia treatment (0.505) |
Neuroprotector (0.938) Anti-hypercholesterolemic (0.912) Atherosclerosis treatment (0.548) |
Respiratory analeptic (0.984) Immunomodulator (HIV) (0.933) Anesthetic general (0.917) |
* Only activities with Pa > 0.5 are shown.